Sign In
NewsRadar

KREATECH Diagnostics (acquired by Leica)

Kreatech Diagnostics is a molecular diagnostics company focused on the development and commercialization of DNA probes and nucleic acid labeling technologies that are utilized for diagnostics and research applications in the life sciences and healthcare industry, specifically cytogenetics, molecular pathology, and microarrays.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Vlierweg 20
Amsterdam 1032 LG
Netherlands
+31 20 691 91 81
+ 31 20 630 42 47
http://www.kreatech.com
Harald Berninger
+31 20 691 91 81

Company Facts
Founded:Jan 1990
Founders:Hendrik-Jan Houthoff, Herman Volkers
CEO:Kees Moonen
CTO or technical lead:Herman Volkers
CFO or finance director:
Head of Sales:Harald Berninger
Head of Marketing:Harald Berninger

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Diagnostics
Employees:50
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:No

Non-executive Board Members

Key Customers

Key Business Partners

  • Qiagen
  • PerkinElmer
  • Sigma
  • QBiogene
  • Roche

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    20,163
    Tech investments
    From our Online Data Service
    13,006
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Jul 3€14.2MEnergy related
    Jul 2N/ASensors
    Jul 1€0.1MInternet services
    Jun 30€11.4MInternet services
    Jun 30N/AInternet services
    Jun 30€4.2MDiagnostics
    Jun 29€0.6MSensors

    For information on Europe's most extensive database on technology funding click here!

    Events


    BIO-Europe 2015
    November 2 - 4, 2015

    CONNECTIONS Europe
    November 10 - 11, 2015


    Press Releases


    Jul 6
    CEVEC Pharmaceuticals
    cevec's cap(r)go derived recombinant placental human alkaline phosp...

    Jul 2
    Crunchfish
    crunchfish completes investment to fuel expansion of social proximi...

    Jul 2
    Wilson Therapeutics
    wilson therapeutics appoints hans schikan to its board of directors

    Jul 1
    NightBalance
    nightbalance strengthens competitive position in sleep apnea market...

    Jun 30
    Enevo
    smart city waste logistics system provider enevo receives $ 15.8 mi...





    About usContact usLegal Information
    Copyright 1999-2015
    Emerging Technology Research Europe Inc. All rights reserved.